Pharmaceutical R&D decisions carry significant financial and operational weight for small and midsize companies. Without a full internal team, these challenges are often difficult to navigate, potentially leading to delays, rework, and lost time on the market. In this guide, Kiel Laboratories’ experts share strategies to de-risk your program with an external strategic partner.
Download your copy to explore:
- Reasons to consider an external partner, including expertise, capacity, and flexibility
- Questions to help clarify goals for pharma R&D and regulatory strategy
- An overview of functions well-suited for external partnership, as well as those that are commonly kept in-house
- Qualities to look for in an ideal pharmaceutical R&D partner and red flags to avoid
- Practical steps to set your partnership up for success, including aligning expectations and scaling support across development stages